2172MicroPort NeuroTech2172 info
$0.99info1.85%24h
Global rank
Market cap$0
Change 7d1.58%
YTD Performance-35.62%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Business data

    MicroPort NeuroTech (2172) Stock Overview

    MicroPort NeuroTech Limited engages in the research and development, production, and sale of neuro-interventional medical devices in the People's Republic of China and internationally. It offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk; Tubridge, a flow-diverting stent; Willis, an intracranial stent graft system; Comaneci, an adjustable temporary coil embolization; and Rebridge, an intracranial visualized stent for use in the treatment of hemorrhagic stroke. The company also provides APOLLO, an intracranial stent a balloon-expandable stent to treat intracranial atherosclerotic disease; Bridge, a rapamycin target eluting vertebral artery stent system; and Diveer, an intracranial balloon catheter to treat cerebral atherosclerosis stenosis. In addition, it offers Neurohawk, a stent thrombectomy device; X-Track, and distal access catheter product; W-track, an intracranial aspiration catheter; and balloon protection guide catheter; and Tigertriever, an adjustable stent retriever for use in the treatment of acute ischemic stroke. Further, it provides Asahi Neurovascular Guidewires and U-track support catheter. The company was founded in 2004 and is headquartered in Shanghai, the People's Republic of China.

    2172 Stock Information

    Symbol
    2172
    Address
    Zhangjiang High-tech ParkShanghai, China
    Founded
    -
    Trading hours
    -
    Website
    https://www.medneurotech.com
    Country
    🇨🇳 China
    Phone Number
    86 21 3895 4600

    MicroPort NeuroTech (2172) Price Chart

    -
    Value:-

    MicroPort NeuroTech Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.9880015551401101
    N/A
    Employees
    575.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org